Literature DB >> 22895578

C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging.

Jeremy M Silverman1, James Schmeidler, Michal S Beeri, Clive Rosendorff, Mary Sano, Hillel T Grossman, José R Carrión-Baralt, Irina N Bespalova, Rebecca West, Vahram Haroutunian.   

Abstract

OBJECTIVES: Identifying phenotypes for successful cognitive aging, intact cognition into late-old age (>age 75), can help identify genes and neurobiological systems that may lead to interventions against and prevention of late-life cognitive impairment. The association of C-reactive protein (CRP) with cognitive impairment and dementia, observed primarily in young-elderly samples, appears diminished or reversed in late-old age (75+ years). A family history study determined if high CRP levels in late-old aged cognitively intact probands are associated with a reduced risk of dementia in their first-degree family members, suggesting a familial successful cognitive aging phenotype.
METHODS: The primary sample was 1,329 parents and siblings of 277 cognitively intact male veteran probands at least 75 years old. The replication sample was 202 relatives of 51 cognitively intact community-ascertained probands at least 85 years old. Relatives were assessed for dementia by proband informant interview. Their hazard ratio (HR) for dementia as a function of the proband's log-transformed CRP was calculated using the proportional hazards model.
RESULTS: Covarying for key demographics, higher CRP in probands was strongly associated with lower risk of dementia in relatives (HR = 0.55 [95% confidence interval (CI) 0.41, 0.74], p < 0.02). The replication sample relationship was in the same direction, stronger in magnitude, and also significant (HR = 0.15 [95% CI 0.06, 0.37], p < 0.0001).
CONCLUSIONS: Relatives of successful cognitive aging individuals with high levels of CRP are relatively likely to remain free of dementia. High CRP in successful cognitive aging individuals may constitute a phenotype for familial-and thus possibly genetic-successful cognitive aging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895578      PMCID: PMC3525301          DOI: 10.1212/WNL.0b013e3182698c89

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Apolipoprotein e genotypes: relationship to cognitive functioning, cognitive decline, and survival in nonagenarians.

Authors:  Lise Bathum; Lene Christiansen; Bernard Jeune; James Vaupel; Matt McGue; Kaare Christensen
Journal:  J Am Geriatr Soc       Date:  2006-04       Impact factor: 5.562

2.  Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias.

Authors:  J M Silverman; J C Breitner; R C Mohs; K L Davis
Journal:  Am J Psychiatry       Date:  1986-10       Impact factor: 18.112

3.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

Review 4.  Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis.

Authors:  Hsu-Ko Kuo; Chung-Jen Yen; Chia-Hsuin Chang; Chen-Ko Kuo; Jen-Hau Chen; Farzaneh Sorond
Journal:  Lancet Neurol       Date:  2005-06       Impact factor: 44.182

5.  The validity of the family history method for identifying Alzheimer disease.

Authors:  G Li; M Aryan; J M Silverman; V Haroutunian; D P Perl; S Birstein; M Lantz; D B Marin; R C Mohs; K L Davis
Journal:  Arch Neurol       Date:  1997-05

6.  Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.

Authors:  M S Beeri; J Schmeidler; M Sano; J Wang; R Lally; H Grossman; J M Silverman
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

7.  A study of the reliability of the family history method in genetic studies of Alzheimer disease.

Authors:  J M Silverman; R S Keefe; R C Mohs; K L Davis
Journal:  Alzheimer Dis Assoc Disord       Date:  1989       Impact factor: 2.703

8.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

9.  Diagnostic validity of the dementia questionnaire for Alzheimer disease.

Authors:  R J Ellis; K Jan; C Kawas; W C Koller; K E Lyons; D V Jeste; L A Hansen; L J Thal
Journal:  Arch Neurol       Date:  1998-03

10.  Evidence for familial factors that protect against dementia and outweigh the effect of increasing age.

Authors:  H Payami; K Montee; J Kaye
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

View more
  15 in total

1.  Long-term systemic inflammation and cognitive impairment in a population-based cohort.

Authors:  Margarete A Wichmann; Karen J Cruickshanks; Cynthia M Carlsson; Rick Chappell; Mary E Fischer; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Carla R Schubert
Journal:  J Am Geriatr Soc       Date:  2014-08-14       Impact factor: 5.562

2.  Outcome age-based prediction of successful cognitive aging by total cholesterol.

Authors:  Jeremy M Silverman; James Schmeidler
Journal:  Alzheimers Dement       Date:  2018-03-05       Impact factor: 21.566

3.  The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old.

Authors:  Jeremy M Silverman; James Schmeidler
Journal:  Med Hypotheses       Date:  2017-10-31       Impact factor: 1.538

4.  The Role of Inflammatory Biomarkers as a Diagnostic Tool for Possible Late-Life Cognitive Decline and Dementias.

Authors:  Marianna Katsoulaki; Alexandros Kastrinis; Xenia Konstantoudaki; Maria Tsekoura
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.

Authors:  Sam Gandy; Vahram Haroutunian; Steven T DeKosky; Mary Sano; Eric E Schadt
Journal:  Biol Psychiatry       Date:  2013-03-01       Impact factor: 13.382

6.  Association of apolipoprotein E-e4 and dementia declines with age.

Authors:  Daniel Valerio; Henriette Raventos; James Schmeidler; Michal S Beeri; Lara Mora Villalobos; Patricia Bolaños-Palmieri; José R Carrión-Baralt; Jaime Fornaguera; Jeremy M Silverman
Journal:  Am J Geriatr Psychiatry       Date:  2014-03-21       Impact factor: 4.105

Review 7.  Epigenetic determinants of healthy and diseased brain aging and cognition.

Authors:  Schahram Akbarian; Michal Schnaider Beeri; Vahram Haroutunian
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

8.  Dementia Risk and Protective Factors Differ in the Context of Memory Trajectory Groups.

Authors:  Laura B Zahodne; Nicole Schupf; Adam M Brickman; Richard Mayeux; Melanie M Wall; Yaakov Stern; Jennifer J Manly
Journal:  J Alzheimers Dis       Date:  2016-04-12       Impact factor: 4.472

Review 9.  Dementia in the oldest old: a multi-factorial and growing public health issue.

Authors:  Raquel C Gardner; Victor Valcour; Kristine Yaffe
Journal:  Alzheimers Res Ther       Date:  2013-07-01       Impact factor: 6.982

10.  C-reactive protein, APOE genotype and longitudinal cognitive change in an older population.

Authors:  Thomas A S Lima; Amanda L Adler; Thais Minett; Fiona E Matthews; Carol Brayne; Riccardo E Marioni
Journal:  Age Ageing       Date:  2013-12-03       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.